Cargando…

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity

SIMPLE SUMMARY: This study seeks to evaluate innate T cells for antitumor therapies that can target both tumor cells and immunosuppressive tumor-associated macrophages (TAMs). With their innate immune-like nature, mucosal-associated invariant T (MAIT) cells, invariant natural killer T (iNKT) cells,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan-Ruide, Brown, James, Yu, Yanqi, Lee, Derek, Zhou, Kuangyi, Dunn, Zachary Spencer, Hon, Ryan, Wilson, Matthew, Kramer, Adam, Zhu, Yichen, Fang, Ying, Yang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179365/ https://www.ncbi.nlm.nih.gov/pubmed/35681730 http://dx.doi.org/10.3390/cancers14112749

Ejemplares similares

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
por: Chen, Yuning, et al.
Publicado: (2023)

Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors
por: Li, Yan-Ruide, et al.
Publicado: (2022)

An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Graft-versus-Host Disease Modulation by Innate T Cells
por: Fang, Ying, et al.
Publicado: (2023)

Target tumor microenvironment by innate T cells
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies
por: Li, Yan-Ruide, et al.
Publicado: (2021)

Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering
por: Lee, Derek, et al.
Publicado: (2023)

Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor Microenvironment
por: Dunn, Zachary Spencer, et al.
Publicado: (2022)

Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8(+) T cell antitumor immunity
por: Pham, Thao N.D., et al.
Publicado: (2022)

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Red-Light-Activatable AND-Gated Antitumor Immunosuppressant
por: Zhou, Ziqi, et al.
Publicado: (2023)

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
por: Li, Yan-Ruide, et al.
Publicado: (2023)

LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization
por: Hu, Jinyang, et al.
Publicado: (2022)

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2021)

The role of innate immune signals in antitumor immunity
por: Jinushi, Masahisa
Publicado: (2012)

Lifting the innate immune barriers to antitumor immunity
por: Rothlin, Carla V, et al.
Publicado: (2020)

Macrophage phenotype in sepsis immunosuppression
por: Theodorakis, E, et al.
Publicado: (2015)

Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses
por: Wang, Hongnuan, et al.
Publicado: (2022)

Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
por: Li, Yan-Ruide, et al.
Publicado: (2023)

Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans
por: Pashov, Anastas, et al.
Publicado: (2010)

Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma
por: Csizmar, Clifford M., et al.
Publicado: (2021)

Osteoclasts Lose Innate Inflammatory Reactivity to Metal and Polymer Implant Debris Compared to Monocytes/Macrophages
por: Yadav, Jessica, et al.
Publicado: (2013)

Immunosuppressive effect of Plantago major on the innate immunity of Galleria mellonella
por: Kaya, Serhat
Publicado: (2023)

Advancements in CRISPR screens for the development of cancer immunotherapy strategies
por: Li, Yan-Ruide, et al.
Publicado: (2023)

Immunosuppression Facilitates the Reactivation of Latent Papillomavirus Infections
por: Maglennon, G. A., et al.
Publicado: (2014)

Prevention of Hepatitis B reactivation in the setting of immunosuppression
por: Pattullo, Venessa
Publicado: (2016)

Immunosuppressants: COVID-19 reactivation: case report
Publicado: (2022)

Innate Immune Memory in Macrophages
por: Maheshwari, Akhil
Publicado: (2023)

Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells
por: Colombo, Miriam, et al.
Publicado: (2022)

Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
por: Wang, Ying, et al.
Publicado: (2022)

Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
por: Ye, Jun, et al.
Publicado: (2021)

The Role of Reactive Species on Innate Immunity
por: Andrés, Celia María Curieses, et al.
Publicado: (2022)

Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response
por: Vienne, Margaux, et al.
Publicado: (2021)

Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy
por: Horiguchi, Hiroyuki, et al.
Publicado: (2018)

Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs
por: Oyarce, Cesar, et al.
Publicado: (2021)

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?
por: Colbeck, Emily Jayne, et al.
Publicado: (2017)

Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment
por: Liu, Yushuai, et al.
Publicado: (2022)

Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation
por: Shen, Yingying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_236ldrp88pfd6hugbadbi1k479